| Literature DB >> 36233855 |
Daniel Diehl1,2, Anton Friedmann1, Pheline Liedloff1, Rico Marvin Jung1, Anton Sculean3, Hakan Bilhan1.
Abstract
The comprehensive treatment of periodontitis stage 2 to 4 aims at the resolution of periodontal inflammation and "pocket closure", which implies a residual probing depth of ≤4 mm and a negative BoP. However, supportive periodontal therapy (SPT) regularly leaves behind persistent periodontal pockets with 5 or more mm in residual PPD and sites that often re-colonize and re-infect. Various adjunctive options for subgingival instrumentation have been proposed to enhance the antimicrobial effects to better control the re-infection of these residual sites. The locally applied adjuncts, based on their anti-inflammatory effect, are sodium hypochlorite antiseptic cleaning gel and cross-linked hyaluronic acid (xHyA). Both recently moved into the focus of clinical research on non-surgical and surgical therapy for periodontitis. The surgical use of xHyA indicates regenerative potential, supporting periodontal regeneration. This case series retrospectively analyzes the clinical benefits of the consecutive flapless application of sodium-hypochlorite-based cleaning gel and xHyA at the SPT to achieve pocket closure, thereby reducing the need for periodontal surgery. In 29 patients, 111 sites received the treatment sequence. At 6-month re-evaluation, an overall PPD reduction exceeding 2 mm was achieved, associated with a similar CAL gain (2.02 mm); the bleeding tendency (BoP) was reduced by >60%. Pocket closure occurred in almost 25% of all the sites. Within their limits, the present data suggest that the proposed combined adjunctive treatment of residual active periodontal sites yielded significant improvement in the clinical parameters. Further studies in RCT format are required to confirm these observations.Entities:
Keywords: hyaluronic acid; non-surgical periodontal therapy; periodontitis; sodium hypochlorite
Year: 2022 PMID: 36233855 PMCID: PMC9571901 DOI: 10.3390/ma15196508
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.748
Figure 1Visualization of the applied treatment protocol. (A) Application of chloramine gel to the pocket for 30–45 s. (B) Scaling and root planning is performed. Chloramine gel may be applied repeatedly until non-surgical treatment is deemed sufficient. (C) Cross-linked hyaluronic acid (xHya) is applied to the pocket until plenished.
Patient demographics and mean clinical parameters before (pre) and after (post = 6 months) the treatment. CAL = clinical attachment level, PPD = probing pocket depth, BOP = bleeding on probing, * = Wilcoxon signed-rank test.
| Patients (Sites) | 29 (111) | |||
|---|---|---|---|---|
| Mean Age (Range) | 54.6 (39–75) | |||
| Sex | ||||
|
Male (%) | 9 (31%) | |||
|
Female (%) | 20 (69%) | |||
| Smokers (%) | 2 (7%) | |||
| Diabetes (%) | 0 | |||
| Pre | Post | CAL gain/PPD Reduction | ||
| CAL | Mean (SD) | 7.96 (±2.2) | 5.95 (±1.8) | +2.02 mm |
| Median | 7 | 6 | ||
| Min | 2 | 2 | ||
| Max | 9 | 13 | ||
| PPD | Mean (SD) | 7.19 (±1.89) | 5.16 (±1.81) | −2.04 mm |
| Median | 6 | 5 | ||
| Min | 4 | 2 | ||
| Max | 15 | 12 | ||
| BOP | 97.6% | 40.1% | ||
Descriptive statistics of PPD and CAL development in furcation-involved sites after combined chloramine and xHya treatment. Pre = baseline, Post = 6 months post treatment, * = Wilcoxon signed-rank test.
| Furcation Involved (n = 12) | Pre | Post | CAL Gain/PPD Reduction | |
|---|---|---|---|---|
| CAL | Mean (SD) | 9.08 (±2.88) | 7.58 (±1.73) | +1.50 mm |
| Median | 9 | 8 | ||
| Min | 6 | 4 | ||
| Max | 16 | 9 | ||
| PPD | Mean (SD) | 8.25 (±2.59) | 5.833 (±1.75) | −2.42 mm |
| Median | 8 | 5.5 | ||
| Min | 6 | 3 | ||
| Max | 15 | 9 | ||
Descriptive statistics of PPD and CAL development in sites without furcation involvement after combined chloramine and xHya treatment. Pre = baseline, Post = 6 months post treatment, * = Wilcoxon signed-rank test.
| No Furcation Involved (n = 99) | Pre | Post | CAL Gain/PPD Reduction | |
|---|---|---|---|---|
| CAL | Mean (SD) | 7.93 (±2.03) | 5.89 (±1.87) | +2.04 mm |
| Median | 7 | 6 | ||
| Min | 5 | 2 | ||
| Max | 13 | 13 | ||
| PPD | Mean (SD) | 6.96 (±1.68) | 5.15 (±1.86) | −1.81 mm |
| Median | 6 | 5 | ||
| Min | 4 | 2 | ||
| Max | 12 | 12 | ||
Figure 2Boxplots for clinical parameters before and after the treatment sequence of non-furcation-involved (A) and furcation-involved (B) sites. Whiskers represent minimum and maximum values. * p < 0.05, ** p < 0.01, **** p < 0.0001. (C) Amount of sites exhibiting bleeding on probing before (upper) and after (lower) the treatment.